Valuation: Oriola Oyj

Market Cap 166M 192M 156M 142M 267M 18.27B 271M 1.83B 715M 9.15B 719M 704M 30.51B P/E 2026 *
90.1x
P/E 2027 * 11.6x
Enterprise Value 105M 121M 98.2M 89.57M 168M 11.54B 171M 1.15B 451M 5.78B 454M 444M 19.26B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.39x
Free-Float
67.86%
Yield 2026 *
2.77%
Yield 2027 * 5.55%
Manager TitleAgeSince
Chief Executive Officer 57 14/03/2022
Director of Finance/CFO 57 15/09/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 63 30/01/2019
Director/Board Member 57 31/12/2022
Chairman 60 31/12/2022
Change 5-day change 1-year change 3-year change Capi.($)
-4.65%-12.39% - - 192M
-2.55%+0.17%+33.34%+99.68% 105B
-2.54%-2.12%+60.05%+153.47% 55.88B
0.00%-0.84%+3.67%+268.32% 24.12B
-0.78%+0.61%-12.93%-14.11% 8.28B
-1.04%+5.66%-30.42%-25.18% 7.75B
-0.54%-2.57%-13.81%-21.97% 6.69B
+0.48%+0.43%+18.27%+16.29% 6.16B
-1.41%-4.96%-5.85%+19.81% 5.01B
-0.59%+2.65%-5.97%-4.99% 3.75B
Average -1.34%+0.29%+5.15%+54.59% 24.75B
Weighted average by Cap. -1.93%-0.28%+29.52%+113.34%

Financials

2026 *2027 *
Net sales 207M 239M 194M 177M 333M 22.83B 338M 2.29B 893M 11.43B 899M 879M 38.11B 217M 251M 204M 186M 349M 23.94B 355M 2.4B 937M 11.98B 942M 922M 39.96B
Net income 1.38M 1.59M 1.29M 1.18M 2.22M 152M 2.25M 15.21M 5.94M 76.07M 5.98M 5.85M 254M 14.35M 16.56M 13.45M 12.26M 23.06M 1.58B 23.41M 158M 61.81M 791M 62.19M 60.84M 2.64B
Net Debt -61.2M -70.64M -57.34M -52.3M -98.33M -6.74B -99.84M -674M -264M -3.37B -265M -259M -11.25B -80.4M -92.8M -75.33M -68.71M -129M -8.85B -131M -886M -346M -4.43B -348M -341M -14.78B
Logo Oriola Oyj
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Employees
796
Trader
Investor
Global
Quality
ESG MSCI
-